跳至主要内容
临床试验/NCT04415541
NCT04415541撤回不适用

Psychodynamic Psychotherapy for Psychosis: An Empirical Pilot Study of Efficacy, Therapeutic Action, and Machine Learning Analysis of Within-Session Speech and Behavior

Yale University0 个研究点开始时间: 2021年5月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Overall Functioning - Social

研究概览

简要总结

The broad goals of our pilot study are to (1) determine whether psychodynamic psychotherapy for psychosis (PPfP), relative to treatment as usual (TaU), can maintain or augment clinical and functional benefits for patients who have achieved initial recovery in our coordinated specialty care (CSC) early psychosis treatment program; (2) to conduct novel empirical study of how various psychodynamic factors may inform candidate selection, mediate therapeutic effects, and influence relational aspects of the therapy; and (3) to conduct a detailed study of how features of therapist and patient speech and behavior influence therapeutic outcomes, therapeutic alliance alliance, and relational process. This registration focuses on the first goal.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 35 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • completed the 2-3 year Coordinated Specialty Care (CSC) program
  • judged by present provider to be in an intermediate or advanced phase of recovery
  • had first episode of psychosis within the 3 years prior to enrollment

排除标准

  • established diagnosis of primary affective disorder, psychosis secondary to substance use or a medical illness
  • inability to communicate in English
  • eligibility for Department of Developmental Services
  • legally mandated to enter treatment.

结局指标

主要结局

Overall Functioning - Social

时间窗: From enrollment up to 5 years from enrollment.

The Global Functioning: Social scale will be used, with symptoms rated 1 (most impaired) to 10 (superior functioning).

Overall Symptom Severity

时间窗: From enrollment up to 5 years from enrollment.

The Positive and Negative Symptom Scale (PANSS) will be used. This is a 30 item scale. Each item is measured on a 7-point scale from 1 (absent) to 7 (extreme). Items are summed to obtain an overall score.

Overall Functioning - Role

时间窗: From enrollment up to 5 years from enrollment.

The Global Functioning: Role scale will be used, with symptoms rated 1 (most impaired) to 10 (superior functioning).

次要结局

  • Symptom Severity (Positive Symptoms)(From enrollment up to 5 years from enrollment.)
  • Symptom Severity (Negative Symptoms)(From enrollment up to 5 years from enrollment.)

研究者

申办方类型
Other
责任方
Sponsor

相似试验